Toxicovigilance : A prerequisite to drug safety surveillance in Ayurveda by Dr. Smitha Jain et al.
  
 
ISSN: 2456-3110                                                       REVIEW ARTICLE Nov-Dec 2018 
 
Journal of Ayurveda and Integrated Medical Sciences | Nov - Dec  2018 | Vol. 3 | Issue 6 144 
 
Toxicovigilance : A prerequisite to drug safety 
surveillance in Ayurveda 






Professor, Dept. of Agada Tantra, Sri Dharmasthala Manjunatheshwara  






















The concept of toxicovigilance encompasses the 
active detection, validation and follow-up of clinical 
adverse events related to toxic exposures in human 
beings.
[1]
 Agada Tantra, a branch of Ashtanga 
Ayuveda, deals with toxic effects of Visha Dravyas 
(toxic substances) and their impact on  health. Science 
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of Ayurveda emphasizes the usage of Visha Dravyas 
(toxic substances) of herbal/metallic/mineral origin as 
medicine after Shodhana (purification/detoxification 
process). Charaka explains “even a strong poison can 
become an excellent medicine if administered 
properly; on the other hand, even the most useful 
drug can act as a poison if handled carelessly”.
[2] 
Hence dose differentiates a drug from poison. The 
pharmacology concepts and drug safety issues are 
vigorous all through the literatures of Ayurveda, but 
absolute methods to estimate drug safety is not 
pursued.  
Improvement of patient safety is gaining momentum 
world wide, so the subject of drug safety has become 
vital in the present scenario. The detection, 
assessment and prevention of adverse events and all 
other problems related to medicines are considered 
under pharmacovigilance. As adverse drug reactions 
(ADR) reports under pharmacovigilance raises high 
A B S T R A C T  
Toxicovigilance is the active process of identifying and evaluating the toxic risks existing in a 
community and evaluating the measures to reduce or eliminate them. Although the technical term 
“toxicovigilance” does not feature in Ayurvedic texts, its essence is highlighted in Agada Tantra.  
Agada Tantra has comprehensive approach on toxic effects of Visha Dravyas (toxic substances) and its 
management. Through toxicovigilance; not merely there is scope for Ayurveda to find solution for 
toxicity issues, besides there is extensive scope for screening and regulating Ayurvedic formulations 
containing poisonous drugs of herbal/metal/mineral origin. In fact, study of poisonous drugs and ADR 
monitoring is an essential aspect in toxicological departments.  It is the need of the hour to employ 
the Ayurvedic discipline of toxicology to explore the challenges that Ayurveda is facing today with 
regard to drug safety.  A comprehensive study of all potential exposure associated with Ayurvedic 
medicaments, risk assessment, prevention and management can be the primary footstep in this 
direction. At this point, vigilance of toxic drugs is to be done by considering the guidelines on 
collection, pharmaceutical processing, indications, contraindications, dosage and antidotes as 
mentioned in Ayurvedic classics. Thus, data of toxicovigilance can be effectively applied in monitoring 
drug safety in Ayurveda.  
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concern towards formulations containing toxic 
medicinal plants, metals and minerals; an attempt 
towards drug safety needs to be started with 
screening and regulating Ayurvedic formulations 
containing poisonous drugs. In fact, study of 
poisonous drugs and adverse drug reactions (ADR) 
monitoring is crucial in toxicological department. Due 
to numerous formulations and also due to diversity in 
drug choice, it is extremely difficult to ascertain fixed 
safety standards for herbal preparations. The classical 
references about poisonous compounds are scattered 
and there is difference of opinion about 
pharmaceutical processing, indications and dosage of 
these drugs. Detailed study of toxic drugs i.e. 
toxicovigilance from Ayurveda point of view will be a 
basic requirement towards drug safety. This will guide 
towards the prominent areas of research and thereby 
helpful in establishing the standards. Accordingly an 
attempt is made to review the Ayurveda manuscripts 
regarding the therapeutic utilization of toxic drugs in 
Ayurveda and to appraise application of 
toxicovigilance in monitoring drug safety. 
Scope of poisonous substances in Ayurveda 
Schedule-E(1) of Drugs & Cosmetic Act 1940 has 
enlisted 13 herbal, 1 animal origin and 7 mineral 




application of Visha-Upavisha Dravyas (toxic 
medicinal plants) is extensive in Ayurveda. 
Formulations containing Visha-Upavisha Dravyas 
(toxic medicinal plants) have broad clinical 
significance in present day to day practice. In order to 
ascertain the formulations containing Visha-Upavisha 
Dravyas (toxic medicinal plants); search of literature 
was carried out in authoritative books of Ayurveda 
mentioned in Schedule I of Drugs and Cosmetic act 
1940.
[3]
 Vast number of formulations containing toxic 
medicinal plants (shown in Table 1)  and application of 
these formulations in day today clinical practice 
(shown in Table 2)  suggest about wide scope of 
Visha-Upavisha Dravyas (toxic medicinal plants) in 
Ayurvedic therapeutics. In addition, formulations 
containing metal/mineral origin substances are 
innumerous and they have extremely broad scope in 
Ayurveda therapeutics. 
Table 1: Showing the number of formulations 
containing Visha-Upavisha Dravyas (toxic medicinal 
plants) as one of the ingredient. 
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Table 2: Showing few important formulations of 
Visha-Upavisha Dravyas (toxic medicinal plants) that 
are frequently used in practice. 
Drug name Important formulations 
Vatsanabha  Hinguleshwara Rasa (B.R) 
Tribhuvana Keerthi Rasa (Y.R) 
Agnitundi Vati (R.S.S) 
Anandabhairava Rasa (R.S.S) 
Maha Shankha Vati (B.R) 
Vishagarbha Thaila (Y.R) 
Kupeelu  
 
Agnitundi Vati (R.S.S) 
Vishamushti Vati (S.B.M.M) 
Lakshmi Vilasa Rasa (B.R) 
Visha Garbhathaila (B.R) 
Vishatinduka Thaila (B.R) 
Ahiphena  Ahiphenasava (B.R) 
Grahani Kapata Rasa (B.R) 
Kaprura Rasa (B.R) 
Jayapala  Icchabhedhi Rasa (B.R.) 
Punarnavadi Mandoora (B.R) 
Draksha Asava (B.R)  
Dadimavaleha (Y.R) 
Dhatura Mahajwarankush Rasa (R.R.S) 
Lakshmivilas Rasa (B.R) 
Mahalakshamivilas Rasa (B.R) 
Unmadagajankush (R.T) 
Kanakasava (B.R)  
Vishagarbha Thaila (Y.R) 
Maha Visha Garbha Thaila (Y.R) 
Bhanga  Pushpadhanwa Rasa (B.R) 
Jatiphaladi Churna (Sha.Sam.) 
Gunja  Gunjabhadra Rasa (R.T) 
Gunja Thaila (B.R) 
Indraluptahara Lepa (Sha. Sam) 
Bhallataka  Sanjivani Vati (A.F.I)  
Amrtabhallataka Ghrita (A.F.I.) 
Kutaja Avaleha (A.F.I)  
Prasarini Taila (A.F.I) 
Panchatikta Guggulu Gritha (B.R) 
Arka  Arka Lavana  (B.R.) 
Dhanvanthari Ghritha  (Sa.Yo.) 
Marichadi Taila  (Sha.Sam.) 
Pravala Panchamritham (Y.R) 
Snuhi  Shankha Vati (B.R) 
Marichadi Taila (C.D) 
Shadbindu Taila (B.R) 
Langali  Bolabaddha Rasa (R.R.S) 
Karanja Thaila (B.R.) 
Somarajee Thaila (B.R.) 
Karaveera  Manikya Rasa (B.R) 
Mahamarichadi Thaila (Y.R.) 
B.R - Bhaisajya Ratnavali;
[5] 
R.T - Rasa Tarangini;
[6]
 Sha.Sam - 
Sharangadhar Samhita;
[7]
  Y.R. - Yoga Ratnakara;
[8]
 R.R.S - Rasa 
Ratna Samucchaya;
[9]
 S.Y - Sahasra Yoga;
[10]
 C.D - Chakra Datta;
[11]
 
R.S.S. - Rasendra Sara Sangraha;
[12]




Factors for appraisal of toxic drugs in Ayurveda 
Ayurveda has emphasized on specific factors that are 
majorly responsible for the action of drugs. 
Consideration of factors such as collection and 
processing of raw materials, dosage and mode of 
administration, duration/course of drug 
administration, specific diet regimen is extremely 
crucial in administration of Visha-Upavisha Dravyas 
(toxic medicinal plants) because even a trivial 
variation may cause severe ADR’s. Good agricultural 
and collection practices (GACP) to be stringently 
followed in case of toxic herbs collection. Shodhana 
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for each drug is unique and Ayurveda classics 
recommend diverse Shodhana methods for each 
poisonous compound. Standardization of processing 
technique and adoption of standardized guidelines in 
manufacturing the drugs is essential to avoid the 
ADR’s. From pharmacological point of view during 
preparation of the medicines, if the raw drugs are not 
taken in the proper quantity then desired action on 
body may not be obtained or the formulation may 
show unwanted actions. Adverse drug reactions (ADR) 
are also results of improper dose of drugs and 
repeated/large doses. It is the dose by which Visha 
(poison) becomes Amruta (nector) and Ausadha 
(medicine) becomes Visha (poison). Along with 
dosage, additive drug effect also needs to be 
considered while prescribing multiple formulations. 
Eliciting drug history in patients with pre-existing 
kidney or liver disorders may reduce magnitude of 
complications that may arise due to overdosing of 
formulations containing toxic ingredients. Specific 
Anupana (adjuvant) as explained in Ayurveda classics 
have definite role in drug efficacy and safety. Jayapala 
(Croton tiglium) being the best example to show its 
purgative effect enhanced and suppressed by intake 
of cold water and hot water respectively.
[14]
 
References of drug specific diet and regimen 
explained in Ayurveda, enlightens us on the care 
adopted in the system to prevent ADRs. One such 
example being indication of Ghrutha, Ksheera and 
Shashtika Shali use during the administration of 
Bhallathaka (Semicarpus anacardium) owing to its 
extreme Teekshna, Ushna Gunas.
[15]
  Hence these 
factors are to be essentially considered by an 
individual physician and accordingly rational 
prescription of the drugs will accomplish safety. As a 
general rule most of the formulations containing 
metal/mineral drugs, have to be discontinued 
following a period of 45 days. Improving patient 
awareness on diet, regimen, and duration of drug 
administration will bring down common 
misconception amongst the community that all 
Ayurvedic medicines are always safe and absolutely 
devoid of side effects. There is reported evidence 
about overdose effect of Mahashankha Vati, an 
Ayurvedic medicine containing aconite;
[16]
 which was 
consumed without the prescription. It clearly 
demonstrates lack of awareness in patient community 
about Ayurvedic medicines and ill effects of over the 
counter sale. Patient education on appropriate intake 
of medication also avoids the medication errors and 
thereby reduces the ADRs.   
CONCLUSION 
Drug safety is achievable by the three tiers such as 
detection, monitoring and prevention of adverse 
events. Toxicovigilance has a pivotal role in the 
preventive tier of drug safety. Creating 
comprehensive, unbiased and easily accessible 
information on poisonous drugs used in Ayurveda 
therapeutics can build awareness among Ayurvedic 
physicians, drug manufacturers and patients which is 
the need of the hour. 
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